197 related articles for article (PubMed ID: 24800232)
1. MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis.
Liu YX; Long XD; Xi ZF; Ma Y; Huang XY; Yao JG; Wang C; Xing TY; Xia Q
Biomed Res Int; 2014; 2014():482926. PubMed ID: 24800232
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the precursor microRNAs and aflatoxin B1-related hepatocellular carcinoma.
Long XD; Huang XY; Yao JG; Liao P; Tang YJ; Ma Y; Xia Q
Mol Carcinog; 2016 Jun; 55(6):1060-72. PubMed ID: 26152337
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis.
Huang XY; Yao JG; Huang HD; Wang C; Ma Y; Xia Q; Long XD
Gastroenterol Res Pract; 2013; 2013():804128. PubMed ID: 24204382
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population.
Long XD; Ma Y; Zhou YF; Ma AM; Fu GH
Hepatology; 2010 Oct; 52(4):1301-9. PubMed ID: 20658464
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma.
Long XD; Yao JG; Zeng Z; Ma Y; Huang XY; Wei ZH; Liu M; Zhang JJ; Xue F; Zhai B; Xia Q
Hepatology; 2013 Jul; 58(1):171-81. PubMed ID: 23390017
[TBL] [Abstract][Full Text] [Related]
6. Interaction of DNA repair gene polymorphisms and aflatoxin B1 in the risk of hepatocellular carcinoma.
Yao JG; Huang XY; Long XD
Int J Clin Exp Pathol; 2014; 7(9):6231-44. PubMed ID: 25337275
[TBL] [Abstract][Full Text] [Related]
7. Mutational spectra of aflatoxin B
Chawanthayatham S; Valentine CC; Fedeles BI; Fox EJ; Loeb LA; Levine SS; Slocum SL; Wogan GN; Croy RG; Essigmann JM
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3101-E3109. PubMed ID: 28351974
[TBL] [Abstract][Full Text] [Related]
8. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
[TBL] [Abstract][Full Text] [Related]
9. Distinct response of the hepatic transcriptome to Aflatoxin B1 induced hepatocellular carcinogenesis and resistance in rats.
Shi J; He J; Lin J; Sun X; Sun F; Ou C; Jiang C
Sci Rep; 2016 Aug; 6():31898. PubMed ID: 27545718
[TBL] [Abstract][Full Text] [Related]
10. The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China.
Long XD; Ma Y; Qu DY; Liu YG; Huang ZQ; Huang YZ; Lin ZH; Wei NB; Zhou SC
Ann Epidemiol; 2008 Jul; 18(7):572-8. PubMed ID: 18504145
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.
Long XD; Zhao D; Wang C; Huang XY; Yao JG; Ma Y; Wei ZH; Liu M; Zeng LX; Mo XQ; Zhang JJ; Xue F; Zhai B; Xia Q
Epidemiology; 2013 Sep; 24(5):671-81. PubMed ID: 23788213
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
Shen HM; Ong CN
Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
[TBL] [Abstract][Full Text] [Related]
13. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
15. Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma.
Rieswijk L; Claessen SM; Bekers O; van Herwijnen M; Theunissen DH; Jennen DG; de Kok TM; Kleinjans JC; van Breda SG
Toxicology; 2016 Mar; 350-352():31-9. PubMed ID: 27153756
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (RSPO2).
Xu Y; Ge K; Lu J; Huang J; Wei W; Huang Q
Biomed Pharmacother; 2017 Sep; 93():334-343. PubMed ID: 28651234
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma.
Ferreira RG; Cardoso MV; de Souza Furtado KM; Espíndola KMM; Amorim RP; Monteiro MC
Transl Res; 2019 Feb; 204():51-71. PubMed ID: 30304666
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
[TBL] [Abstract][Full Text] [Related]
19. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
[TBL] [Abstract][Full Text] [Related]
20. miR-23c suppresses tumor growth of human hepatocellular carcinoma by attenuating ERBB2IP.
Zhang L; Wang Y; Wang L; Yin G; Li W; Xian Y; Yang W; Liu Q
Biomed Pharmacother; 2018 Nov; 107():424-432. PubMed ID: 30103114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
